UK markets closed

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.71+8.27 (+79.21%)
At close: 04:00PM EDT
18.63 -0.08 (-0.42%)
After hours: 04:04PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.44
Bid18.71 x 40700
Ask18.71 x 28000
Day's range18.36 - 18.72
52-week range8.82 - 21.86
Avg. volume889,701
Market cap781.754M
Beta (5Y monthly)1.22
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Intercept Pharmaceuticals Stock Is Skyrocketing Today

    Intercept is on track to be acquired by Alfasigma at a significant premium compared to recent prices.

  • Motley Fool

    Why CymaBay Therapeutics Stock Is Jumping Today

    The continued momentum is a result of CymaBay's announcement yesterday of positive top-line results from a late-stage clinical study evaluating experimental drug seladelpar in treating primary biliary cholangitis (PBC), a rare chronic inflammatory liver disease. The great news for CymaBay, though, is that seladelpar appears to have a key advantage over those other PBC treatments. The results from the company's phase 3 study found that it significantly reduced itching, which is a major issue for many PBC patients.

  • Zacks

    Why Is Fate Therapeutics (FATE) Down 23.5% Since Last Earnings Report?

    Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.